Advertisement

Response to letter entitled: Re: ‘Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial’

  • Author Footnotes
    1 Equal contribution to this article.
    Changying Shi
    Correspondence
    Corresponding author: Department of Hepatology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, No.225, Changhai Rd., Shanghai, China.
    Footnotes
    1 Equal contribution to this article.
    Affiliations
    Department of Hepatology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, Shanghai, China
    Search for articles by this author
  • Author Footnotes
    1 Equal contribution to this article.
    Yong Li
    Footnotes
    1 Equal contribution to this article.
    Affiliations
    Department of Radiation Oncology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, Shanghai, China

    Center of Radiation Oncology, Wujing Hospital, Shanghai, China
    Search for articles by this author
  • Author Footnotes
    1 Equal contribution to this article.
    Li Geng
    Footnotes
    1 Equal contribution to this article.
    Affiliations
    Department of Hepatology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, Shanghai, China
    Search for articles by this author
  • Weifeng Shen
    Affiliations
    Department of Hepatology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, Shanghai, China
    Search for articles by this author
  • Chengjun Sui
    Affiliations
    Department of Hepatology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, Shanghai, China
    Search for articles by this author
  • Binghua Dai
    Affiliations
    Department of Hepatology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, Shanghai, China
    Search for articles by this author
  • Jiongjiong Lu
    Affiliations
    Department of Hepatology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, Shanghai, China
    Search for articles by this author
  • Mianshun Pan
    Affiliations
    Center of Radiation Oncology, Wujing Hospital, Shanghai, China
    Search for articles by this author
  • Jiamei Yang
    Correspondence
    Corresponding author: Department of Hepatology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, No.225, Changhai Rd., Shanghai, China.
    Affiliations
    Department of Hepatology, Eastern Hepatobiliary Surgery Hospital, Affiliated to Second Military Medical University, Shanghai, China
    Search for articles by this author
  • Author Footnotes
    1 Equal contribution to this article.
      We are writing to respond to Duan et al.’s comments concerning our article titled, ‘Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial.’ We thank these authors for their constructive feedback.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Oguro S.
        • Yoshimoto J.
        • Imamura H.
        • Ishizaki Y.
        • Kawasaki S.
        Clinical significance of macroscopic no-margin hepatectomy for hepatocellular carcinoma.
        HPB (Oxford). 2018 Sep; 20: 872-880https://doi.org/10.1016/j.hpb.2018.03.012
        • Xie D.Y.
        • Ren Z.G.
        • Zhou J.
        • Fan J.
        • Gao Q.
        2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.
        Hepatobiliary Surg Nutr. 2020 Aug; 9 (PMID: 32832496; PMCID: PMC7423548): 452-463https://doi.org/10.21037/hbsn-20-480
        • Reig M.
        • Forner A.
        • Rimola J.
        • Ferrer-Fàbrega J.
        • Burrel M.
        • Garcia-Criado Á
        • et al.
        BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update.
        J Hepatol. 2022 Mar; 76: 681-693https://doi.org/10.1016/j.jhep.2021.11.018
        • Llovet J.M.
        • Kelley R.K.
        • Villanueva A.
        • Singal A.G.
        • Pikarsky E.
        • Roayaie S.
        • et al.
        Hepatocellular carcinoma.
        Nat Rev Dis Prim. 2021 Jan 21; 7: 6https://doi.org/10.1038/s41572-020-00240-3

      Linked Article